| Structure |
Chemical Name |
CAS |
MF |
 |
(6R,7S)-7-ACCA |
108260-07-7 |
C7H7ClN2O3S |
 |
Ornidazole Impurity G |
|
|
 |
rel-(αR*,α'S*)-1-メチル-α,α'-ジフェニル-2α*,6α*-ピペリジンジエタノール |
552-72-7 |
C22H29NO2 |
 |
Gefitinib Impurity S |
|
|
 |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
2037385-84-3 |
C13H19ClN4O3 |
 |
Rosuvastatin Related Compound 8 |
521974-01-6 |
C13H23ClO4 |
 |
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-(formylamino)-, ethyl ester, (3R,4R,5S)- |
2148317-96-6 |
C17H28N2O5 |
![(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/1445580-43-7.gif) |
(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
1445580-43-7 |
C14H21N5O5S |
 |
Trenbolone Acetate Process Impurity 4 |
5218-51-9 |
C18H24O2 |
 |
Ticagrelor Impurity 101 |
|
|
![2-[3-(メチルアミノ)-1-(チオフェン-2-イル)プロピル]ナフタレン-1-オール](/CAS/20180527/GIF/1033803-59-6.gif) |
2-[3-(メチルアミノ)-1-(チオフェン-2-イル)プロピル]ナフタレン-1-オール |
1033803-59-6 |
C18H19NOS |
 |
Aprepitant iMpurity 40 |
|
|
 |
Voriconzolegenotoxicimpurity |
|
|
 |
Rocuronium Bromide Impurity 22 |
|
|
 |
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
 |
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
 |
3-O-TERT-ブチルジメチルシリルカルシフェジオール |
140710-90-3 |
C33H58O2Si |
![5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethanol](/CAS/GIF/112935-93-0.gif) |
5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethanol |
112935-93-0 |
C14H20N2O5 |
 |
Vonoprazan impurity A |
|
|
 |
Afatinib Impurity 57 |
|
|
 |
N-(2-フェノキシフェニル)メタンスルホンアミド |
51765-51-6 |
C13H13NO3S |
 |
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
1610043-62-3 |
C12H13FN2 |
 |
Ipragliflozin Impurity 4 |
|
|
 |
Ixazomib Impurity 2 |
|
|
 |
Hydroxychloroquine Impurity K |
|
|
 |
Prasugrel Impurity 11 |
|
|
 |
REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane |
139757-68-9 |
C8H11N3O3S |
 |
1,6,10,14-Hexadecatetraen-3-ol, 3,7,11,15-tetramethyl-, (6Z,10E)- |
3790-76-9 |
C20H34O |
 |
EzetiMibe Dehydoxy IMpurity |
204589-58-2 |
C24H21F2NO2 |
 |
Budesonide Impurity 21 |
|
|
 |
Beprostatin impurity 4 |
|
|
 |
Benazepril impurity A |
|
C24H28N2O5 |
 |
Cefminox Impurity 1 |
|
|
 |
3-Hydroxy-4-Methyl-2(5H)-thiophenone |
34876-35-2 |
C5H6O2S |
 |
Dolutegravir Impurity 14(Sodium Salt) |
|
|
 |
Cabozantinib impurity S |
|
|
 |
Ticagrelor Impurity 12 |
|
|
 |
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid Gd3+ |
|
|
![(S)-6-chloro-7-methyl-2-(2-methyl-1-nitrosopyrrolidin-2-yl)-1H-benzo[d]imidazole](/CAS/20250703/GIF/3112735-67-5.gif) |
(S)-6-chloro-7-methyl-2-(2-methyl-1-nitrosopyrrolidin-2-yl)-1H-benzo[d]imidazole |
3112735-67-5 |
C13H15ClN4O |
 |
SalMeterol IMpurity C |
|
C25H37NO4 |
 |
Pyrazinecarboxylic acid, 5-methyl-, 1-oxide (9CI) |
98502-96-6 |
C6H6N2O3 |
 |
cefoxitin iMpurity C |
|
|
 |
21-Acetyl-6β-fluorotriamcinolone Acetonide |
67438-37-3 |
C26H32F2O7 |
 |
Dapoxetine impurity 65 |
|
|
 |
2-((R)-3-(diisopropylamino)-1-phenylpropyl)-4-(1-hydroxyethyl)phenyl isobutyrate |
|
C27H39NO3 |
 |
Canagliflozin alpha-Isomer Impurity |
|
|
 |
Avatrombopag Impurity 39 |
|
|
 |
Mannitol EP impurity A |
|
|
 |
Doxofylline iMpurity C |
|
|
 |
Rocuronium Bromide Impurity 24 |
|
|
 |
Oseltamivir Impurity Mixture (MW:486 Da) |
|
|
 |
Canagliflozin Impurity 84 |
|
|
![5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid](/) |
5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid |
|
|
![3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン](/CAS/GIF/54528-00-6.gif) |
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
 |
Terazosin EP Impurity D |
102714-74-9 |
C15H19N5O3 |
 |
Terbutaline Impurity 18 |
|
|
 |
D-biotin-d-sulfoxide |
10406-89-0 |
C10H16N2O4S |
 |
Cefadroxil Impurity C |
79962-91-7 |
C16H17N3O5S |
 |
Dexamethasone Impurity A |
|
|
 |
Celecoxib Impurity 21 |
2055787-31-8 |
C17H12F3N3O3S |
 |
Carvedilol Impurity DBA |
3258-70-6 |
C18H23NO4 |
 |
Exemestane Impurity 5 |
|
|
 |
Tenofovir Impurity 61 |
|
|
 |
Trifluridine Impurity B |
|
|
 |
N-(4-アミノ-6,7-ジメトキシキナゾール-2-イル)-N-メチルプロピレンジアミン塩酸塩 |
81403-69-2 |
C14H21N5O2.ClH |
 |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
 |
N-(5-(benzyl(methyl)amino)-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide |
|
C25H23N5O |
 |
Isavuconazole Impurity 15 |
|
|
 |
Dapagliflozin Impurity 6 |
|
|
 |
Afatinib impurity 48 |
|
|
 |
Cetrorelix Impurity 15 |
|
|
 |
Clopidogrel Impurity 55 |
|
|
 |
イカリシドB5 |
114226-08-3 |
C19H32O8 |
 |
TetrazepaM IMp. C (EP): 7-Chloro-5-cyclohexyl-1-Methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
|
 |
Edoxaban Impurity 12 (1R,2R,4S) |
|
|
 |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-(benzyloxy)quinolin-2(1H)-one) |
753498-27-0 |
C49H49N3O6 |
 |
Brivaracetam Impurity 32 |
|
|
 |
Zileuton Impurity (MW = 279.31 Da) |
|
|
 |
1-(4-(2-Methoxyethyl)phenoxy)-3-(oxiran-2-ylMethoxy)propan-2-ol |
1416440-64-6 |
C15H22O5 |
 |
Oseltamivir Impurity 18 |
|
|
 |
Ibrutinib Impurity 13 |
|
C27H31N7O2 |
 |
8-ヒドロキシミルタザピン |
102335-57-9 |
C17H19N3O |
![Bis[(2-guanidino-4-thiazolyl)methyl]disulfide (85%)(Famotidine Impurity)](/CAS2/GIF/129083-44-9.gif) |
Bis[(2-guanidino-4-thiazolyl)methyl]disulfide (85%)(Famotidine Impurity) |
129083-44-9 |
C10H14N8S4 |
 |
Axitinib Impurity 2 |
1428728-83-9 |
C44H36N8O2S2 |
 |
Rosuvastatin Impurity 147 |
|
|
 |
Sugammadex sodium Impurity 40 |
|
|
![isopropyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate](/) |
isopropyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
|
|
 |
(235U)ウラン |
15117-96-1 |
U |
![1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)-](/CAS/20211123/GIF/936226-36-7.gif) |
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
 |
エルタペネム二量体型D不純物 |
1199797-41-5 |
C44H50N6O14S2 |
 |
Abiolone Impurity 24 |
|
|
 |
Telmisartan impurities1039 |
2031272-32-7 |
C47H40N4O4 |
 |
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
1810761-43-3 |
C15H16N2O3S |
![Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride](/) |
Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride |
|
|
 |
Cilastatin Isomer Impurity |
|
|
 |
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
 |
ビス(2,4-キシリル)ペルスルフィド |
13616-83-6 |
C16H18S2 |
 |
Atracurium Impurity 2 |
|
|
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
 |
Febuxostat Impurity 68 |
|
|